J J Schentag

Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.

M E Plaut, J J Schentag, W J Jusko, 1979, Journal of medicine.

Tissue persistence of gentamicin in man.

M E Plaut, J J Schentag, W J Jusko, 1977, JAMA.

Intravenous theophylline therapy: nomogram guidelines.

J J Schentag, W J Jusko, J W Vance, 1977, Annals of internal medicine.

System for clinical pharmacokinetic monitoring of theophylline therapy.

J J Schentag, W J Jusko, J W Vance, 1976, American journal of hospital pharmacy.

Understanding and managing microbial resistance in institutional settings.

J J Schentag, Jerome J. Schentag, 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory.

J J Schentag, T J Cumbo, Jerome J. Schentag, 1993, Diagnostic microbiology and infectious disease.

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

J J Schentag, R N Jones, Jerome J. Schentag, 1998, Diagnostic microbiology and infectious disease.

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

J J Schentag, A Forrest, Jerome J. Schentag, 1993, Antimicrobial Agents and Chemotherapy.

Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.

J J Schentag, Jerome J. Schentag, A. Cheng, 1999, The Journal of antimicrobial chemotherapy.

Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

J J Schentag, W J Jusko, J W Vance, 1979, Journal of pharmaceutical sciences.

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.

J J Schentag, A Forrest, Jerome J. Schentag, 1999, The Journal of antimicrobial chemotherapy.